Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

322 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Active, not recruiting

An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT02257736

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Phoenix, Arizona, United States
  • La Mesa, California, United States
  • Los Angeles, California, United States
  • Modesto, California, United States
View all 173 locations
View Trial Details
Active, not recruiting

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

NCT04644770

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, not recruiting

A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

NCT04898634

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Columbia University Medical Center Herbert Irving Pavilion New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Washington Seattle, Washington, United States
  • Peking University Third Hospital Beijing, China
View all 17 locations
View Trial Details
Active, not recruiting

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

NCT05288166

Conditions
Abiraterone Acetate, Androgens, Antineoplastic Agents, +27 more
Locations
  • Arizona Oncology Associates, P.C. - HOPE Prescott, Arizona, United States
  • Arizona Oncology Associates, P.C. - HOPE Prescott Valley, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
View all 266 locations
View Trial Details
Active, not recruiting

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

NCT04720157

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Mayo Clinic - Arizona Mayo Clinic Hospital Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of California San Diego - Moores Cancer Center La Jolla, California, United States
  • VA Greater LA Healthcare System Los Angeles, California, United States
View all 167 locations
View Trial Details
Active, not recruiting

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

NCT02446444

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Blacktown Hospital Blacktown, New South Wales, Australia
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
View all 69 locations
View Trial Details

Related conditions